Results of treatment of 255 patients with metastatic renal cell carcinoma who received high-dose recombinant interleukin-2 therapy .15 .盛锡楠,李峻岭,郭军,等.重组人源化白细胞介素-2治疗转移性肾癌的Ⅲ期临床研究.中华肿瘤杂志,2008,30.Prospective randomized t rial of high-dose interleukin22 alone o ......